How Much Did Shorts Play Into July’s Rally? Analysts Upgrade or Downgrade Gap, Lockheed Martin and More

Tuesday's additional top analyst upgrades and downgrades were on Cabaletta Bio, Gap, Lockheed Martin, Northrop Grumman, Spire Global and more.

Published August 30, 2022, 10:25am ET · 3 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A person, seen from behind, wears a brown baseball cap and a tan striped shirt while observing a large digital display. The screen shows a prominent red financial chart with a downward-sloping line against a black grid, indicating a market downturn.
An investor observes a significant market downturn on a red financial chart, reflecting the sentiment as UiPath stock tumbles sharply. © Kevin Frayer / Getty Images

Markets tried to bounce back on Tuesday, with the Nasdaq leading the charge higher with an early gain of about 0.5%. The Dow Jones industrials and S&P 500 were lagging behind, up only 0.2% each, but all the indexes were in the red on last look. All this comes after a couple of consecutive down days on the back of the Federal Reserve reaffirming its narrative of raising interest rates.

Some are suggesting that the bear market rally we saw over the summer might not have been a rally at all. Even though the S&P 500 and Nasdaq bounced over 12% in the month of July, the quick pullback in August might suggest something else—short covering.

As many saw the market on the downtrend since the onset of the Russia-Ukraine conflict in March, it is highly likely that bets against the market were put in place in the form of shorts. Then as these short interest bets were converted, shares must be purchased, sending prices higher. In the midst of the Federal Reserve tightening over the past few months, a 12% bounce seems hard to justify on a bear market rally alone.

24/7 Wall St. is reviewing additional analyst calls seen on Tuesday. We have included the latest call on each stock, as well as a recent trading history and the consensus targets among analysts. Note that analyst calls seen earlier in the day were on Applied Materials, CrowdStrike, Frontier, Lululemon, Peloton and more.

[nativounit]

American Outdoor Brands Inc. (NASDAQ: AOUT): B. Riley Securities upgraded the stock from Neutral to Buy with an $11 price target. The 52-week trading range is $7.10 to $28.14, and the stock traded near $9 on Tuesday.

Ascendis Pharma A/S (NASDAQ: ASND): Berenberg resumed coverage with a Buy rating and a $166 price target. The stock traded near $90 on Tuesday, in a 52-week range of $61.58 to $178.71.

Azure Power Global Ltd. (NYSE: AZRE): Credit Suisse’s downgrade to Underperform from Outperform included a price target cut to $5 from $22. The 52-week trading range is $5.10 to $25.30. Shares changed hands near $5 apiece on Tuesday.

Cabaletta Bio Inc. (NASDAQ: CABA): Morgan Stanley lowered its Overweight rating to Equal Weight and cut the $15 price target to $3. The stock was last seen trading near $1, in a 52-week range of $0.90 to $14.95.

Gap Inc. (NYSE: GPS): Barclays upgraded it to Equal Weight from Underweight and raised the $6 price target to $9. The 52-week trading range is $7.79 to $27.19, and the share price was near $10 on Tuesday.

[recirclink id=1164989]

Lockheed Martin Corp. (NYSE: LMT | LMT Price Prediction): RBC Capital Markets started coverage with a Sector Perform rating and a $460 price target. The shares traded near $428 on Tuesday. The 52-week range is $324.23 to $479.99.

Northrop Grumman Corp. (NYSE: NOC): RBC Capital Markets initiated coverage with a Sector Perform rating and a $550 price target. Shares traded near $485 on Tuesday, in a 52-week range of $344.89 to $497.20.

Sealed Air Corp. (NYSE: SEE): J.P. Morgan upgraded the shares to Neutral from Underweight but cut the $62 price target to $58. Shares have traded as high as $70.72 in the past year but were near $55 on Tuesday, which is down 19% year to date.

Spire Global Inc. (NYSE: SPIR): Canaccord Genuity started coverage with a Buy rating and a $3.50 price target. Shares traded near $1.50 on Tuesday, in a 52-week range of $1.12 to $19.50.

[wallst_email_signup]
The bear market rally that started in June is over and it is clearly a time to move to safer dividend stocks. Eight outstanding health care stocks make sense for worried investors now as they are resistant to inflation or recession fears.

See what analysts are saying about Tesla after its stock split. And with two months left in hurricane season, how do things stand for Gulf oil and gas production?

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →